1. Home
  2. Analysis
  3. Propulsid
  4. Collapse

Propulsid and Collapse - a phase IV clinical study of FDA data

Summary:

Collapse is reported as a side effect among people who take Propulsid (cisapride monohydrate), especially for people who are female, 50-59 old, also take Prilosec,.

The phase IV clinical study analyzes which people have Collapse when taking Propulsid. It is created by eHealthMe based on reports of 8,120 people who have side effects when taking Propulsid from the FDA, and is updated regularly.

What is Propulsid?

Propulsid has active ingredients of cisapride monohydrate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 8,130 Propulsid users. Check the latest studies of Propulsid.

What is Collapse?

Collapse (sudden functional breakdown) is found to be associated with 313 drugs and 93 conditions by eHealthMe. Check the latest studies of Collapse.

On Aug, 04, 2026

8,120 people reported to have side effects when taking Propulsid.
Among them, 59 people (0.73%) have Collapse.

Could Propulsid cause Collapse?

Among these 59 people:

What is the gender of people who have Collapse when taking Propulsid? *

  • female: 66.1 %
  • male: 33.9 %

What is the age of people who have Collapse when taking Propulsid? *

  • 0-1: 0.0 %
  • 2-9: 16.07 %
  • 10-19: 1.79 %
  • 20-29: 0.0 %
  • 30-39: 21.43 %
  • 40-49: 14.29 %
  • 50-59: 28.57 %
  • 60+: 17.86 %

What are other drugs people take besides Propulsid? *

  1. Prilosec: 22 people, 37.29%
  2. Lasix: 21 people, 35.59%
  3. Lanoxin: 9 people, 15.25%
  4. Coumadin: 9 people, 15.25%
  5. Capoten: 9 people, 15.25%
  6. Prevacid: 8 people, 13.56%
  7. Amoxicillin: 7 people, 11.86%
  8. Ancef: 7 people, 11.86%
  9. Gentamicin: 7 people, 11.86%
  10. Meridia: 7 people, 11.86%

What are other side effects people have besides Collapse? *

  1. Ventricular Fibrillation (abnormally irregular heart rhythm): 24 people, 40.68%
  2. Torsade De Pointes (a abnormal heart rate with abnormal beating pattern): 23 people, 38.98%
  3. Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 20 people, 33.90%
  4. Cardiac Arrest: 19 people, 32.20%
  5. Pulse Absent: 16 people, 27.12%
  6. Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 11 people, 18.64%
  7. Fainting (loss of consciousness and postural tone): 11 people, 18.64%
  8. Fever: 10 people, 16.95%
  9. Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 10 people, 16.95%
  10. Cerebral Hypoxia (not enough oxygen getting to the brain): 10 people, 16.95%

* Approximation only. Some reports may have incomplete information.

Do you take Propulsid and have Collapse?

- Check whether Collapse is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Propulsid:

Collapse treatments and more:

How severe was Collapse and when was it recovered:

Expand to all the drugs that have ingredients of cisapride monohydrate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Propulsid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Collapse:

Browse all the conditions that are associated with Collapse:

How the study uses the data?

The study uses data from the FDA. It is based on cisapride monohydrate (the active ingredients of Propulsid) and Propulsid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.